Showing 521-530 of 18560 results for "".
Semaglutide Reduces CV Events in Non-Diabetic, Overweight Patients
https://reachmd.com/programs/diabetes-discourse/semaglutide-reduces-cv-events-in-non-diabetic-overweight-patients/18109/Tune in to find out how semaglutide affects cardiovascular outcomes in patients who are overweight or obese, but do not have diabetes.Political Solutions for the Diabetes Pandemic
https://reachmd.com/programs/clinicians-roundtable/political-solutions-for-the-diabetes-pandemic/1782/Dr. Maurice Pickard discusses with Dr. Nigel Unwin the need for governments to create an environment that allows individuals to make lifestyle changes. The adoption of western culture's poor dietary habits and reduced exercise lifestyles, as well as expanding urban environments fostering these shifWhat Do Young Doctors Know About Diabetes Management?
https://reachmd.com/programs/diabetes-discourse/what-do-young-doctors-know-about-diabetes-management/6463/A new study suggests newly trained physicians may not be adequately prepared to treat patients with diabetes. Host Dr. Steven Edelman, talks with Dr. Stephen Ponder, pediatric endocrinologist at Texas A&M, with 27 years of professional experience in the management of children with diabetes, abKey Considerations for CGM Use in Older Adults with T1D
https://reachmd.com/programs/diabetes-discourse/key-considerations-for-cgm-use-in-older-adults-with-t1d/15156/Get the latest insights on how continuous glucose monitoring can affect older adults with type 1 diabetes.Highlights From Day 3 of the American Diabetes Association's 82nd Scientific Sessions
https://reachmd.com/programs/ada-action-center/highlights-from-day-3-of-the-american-diabetes-associations-82nd-scientific-sessions/13754/Get the highlights from Day 3 of the American Diabetes Association's 82nd Scientific Sessions.Recapping Day 1 of the American Diabetes Association's 82nd Scientific Sessions
https://reachmd.com/programs/ada-action-center/recapping-day-1-of-the-american-diabetes-associations-82nd-scientific-sessions/13752/Here's a breakdown of some of the highlights from Day 1 of the American Diabetes Association's 82nd Scientific Sessions.Updates From Day 2 of the American Diabetes Association's 82nd Scientific Sessions
https://reachmd.com/programs/ada-action-center/updates-from-day-2-of-the-american-diabetes-associations-82nd-scientific-sessions/13753/Get the latest updates from Day 2 of the American Diabetes Association's 82nd Scientific Sessions.Highlights from the Final Days of the American Diabetes Association's 82nd Scientific Sessions
https://reachmd.com/programs/ada-action-center/highlights-from-the-final-days-of-the-american-diabetes-associations-82nd-scientific-sessions/13755/Get the highlights from the final two days of the American Diabetes Association's 82nd Scientific Sessions.The Artificial Pancreas
https://reachmd.com/programs/clinicians-roundtable/the-artificial-pancreas/1104/In this segment Dr. William Tamborlane discusses the management of type 1 diabetes using an artificial pancreas.The Diabetes Breakthrough: Dr. Osama Hamdy on his 12-week Plan
https://reachmd.com/programs/book-club/the-diabetes-breakthrough-dr-osama-hamdy-on-his-12-week-plan/7059/Obesity and sedentary activities have contributed to an epidemic of diabetes mellitus in the US. Is there an answer that is not simply a "fad" diet? Joining host Dr. Maurice Pickard to address this important question is Dr. Osama Hamdy, Medical Director of the Weight Management Program at Joslin Dia